News
-
Sansom & Bell honoured
Wednesday | Sep 5 2018THE International Pharmaceutical Federation (FIP) has highlighted two Australians for their contribution to pharmacy leadership at the 78th World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow.
-
2018 Advancing Practice open
Wednesday | Sep 5 2018APPLICATIONS have opened for the final round of Advancing Practice for 2018, as the program announced final credentialing post-nominals.
-
TGA fires up Facebook
Wednesday | Sep 5 2018JUST when you were thinking it was time to give up your Facebook account because of all the rubbish you are sent, the Therapeutic Goods Administration (TGA) has given you a good reason to stick with the popular advertising medium.
-
Cystic fibrosis and ADHD drugs funded
Wednesday | Sep 5 2018MINISTER for Health Greg Hunt has announced that new cystic fibrosis treatment Orkambi (lumacaftor and ivacaftor) will be listed on the PBS 01 Oct, bringing new hope to 1,200 young Australians and their families.
-
Pharmacy growth forecast by FIP
Wednesday | Sep 5 2018THE International Pharmaceutical Federation says the global pharmacy workforce is expected to expand by up to 40% between 2016 and 2030.
-
Cannabis concerns
Wednesday | Sep 5 2018CANNABIS-BASED medicines should only be used under medical supervision until clinical studies have assessed their safety and efficacy, a University of Queensland drug expert has cautioned.
-
Pharmacy-only brand
Wednesday | Sep 5 2018HEAT Doward has announced it has reached the milestone of selling into more than 500 pharmacies across Australia with its unique confectionery offering, Kelly Candy Co, based on an exclusive distribution agreement.
-
Degludec HbA1c tick
Wednesday | Sep 5 2018USING electronic health record data, researchers found that HbA1c levels declined by 1.5% among insulin degludec-treated patients compared with 1.2% in those treated with insulin glargine U300 over six months, according to a study of real-world data, presented at the American Diabetes Association Scientific Sessions in Orlando, Florida.
-
SGLT2 inhibitor rare genital infections
Wednesday | Sep 5 2018THE US Food and Drug Administration has issued a warning about a serious genital infection that has occurred in patients with diabetes who are taking sodium-glucose cotransporter-2 (SGLT2) inhibitors.
-
Just two days to go
Wednesday | Sep 5 2018WITH registrations nearly selling out, there are now just two days to register for the upcoming Pharmacy Connect conference taking place at the Sydney Hilton 07-08 Sep.
